Biogen Makes Gene Therapy Splash as Street Wonders What's Next

(Bloomberg) -- Biogen Inc.’s plan to buy gene therapy developer Nightstar Therapeutics Plc brings a much needed deal to help diversify away from its high-risk Alzheimer’s drugs, but the pact left s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.